US 12,268,766 B2
Formulations containing active oxygen compounds and devices for application thereof
Dominika Tompa Majcen, Ljubljana (SI)
Appl. No. 17/422,728
Filed by Dominika Tompa Majcen, Ljubljana (SI)
PCT Filed Jan. 14, 2020, PCT No. PCT/IB2020/050257
§ 371(c)(1), (2) Date Jul. 13, 2021,
PCT Pub. No. WO2020/148642, PCT Pub. Date Jul. 23, 2020.
Claims priority of application No. P-201900011 (SI), filed on Jan. 14, 2019.
Prior Publication US 2022/0062124 A1, Mar. 3, 2022
Int. Cl. A61K 8/22 (2006.01); A61K 8/14 (2006.01); A61K 8/34 (2006.01); A61K 8/42 (2006.01); A61K 8/73 (2006.01); A61K 8/9789 (2017.01); A61Q 3/00 (2006.01); A61Q 11/00 (2006.01); A61Q 19/00 (2006.01)
CPC A61K 8/22 (2013.01) [A61K 8/14 (2013.01); A61K 8/345 (2013.01); A61K 8/42 (2013.01); A61K 8/735 (2013.01); A61K 8/9789 (2017.08); A61Q 3/00 (2013.01); A61Q 11/00 (2013.01); A61Q 19/00 (2013.01); A61K 2800/87 (2013.01)] 26 Claims
OG exemplary drawing
 
1. A formulation with active oxygen compounds for maintenance and preservation of a healthy condition of and care for at least one of skin, a tissue, a mucous membrane, a structure of the skin, a system of the skin, a subcutaneous tissue, a fingernail, a toenail, a cuticle, an oral cavity, a system of the oral cavity, a tooth, a periodontal tissue, an interdental space, and their structures and systems, wherein the formulation with active oxygen compounds comprises:
a composition comprising at least one of: a solution, a gel, an emulsion, a lotion, a milk, a spray, a cream, a mouthwash, a paste, and a film dressing; and
a controlled delivery structure included within the composition, wherein the controlled delivery structure comprises a nucleus and a hydrophobic portion, wherein a peroxidase enzyme is included in the hydrophobic portion prior to administration of the composition to a patient, and wherein a source of active oxygen compounds is included within the nucleus prior to administration of the composition to the patient;
wherein the source of active oxygen compounds comprises:
at least one of hydrogen peroxide, benzoyl peroxide, and carbamide peroxide; and
at least one of the following:
(a) silver in colloidal form; and
(b) gold in colloidal form;
wherein the peroxidase enzyme provides controlled release of the active oxygen compounds through controlled breakdown of the source of active oxygen compounds after administration of the composition to the patient.